Navigation Links
Rigel Provides Pipeline Update
Date:10/24/2013

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2013 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced updates on two of the Company's pipeline products: R333, a topical dermatological JAK/SYK inhibitor, and fostamatinib, an oral SYK inhibitor.  

R333 Update
Rigel announced that R333, which was being evaluated as a potential therapeutic for active skin lesions in patients with discoid lupus erythematosus (DLE), did not meet the primary endpoint in a recently completed Phase 2 clinical study.  The primary endpoint was the proportion of patients who achieved at least a 50% decrease from baseline in the total combined Erythema and Scaling score of all treated lesions at Week 4.  R333 was shown to be relatively safe and well tolerated.  In light of these overall findings, Rigel has decided not to pursue this indication further with R333. 

Fostamatinib Update
Rigel representatives met with the FDA for an end-of-Phase 2 meeting for fostamatinib, an oral SYK inhibitor in development for patients with immune thrombocytopenic purpura (ITP).  Rigel expects to initiate two pivotal Phase 3 studies in the first half of 2014.  Each of these trials are expected to enroll approximately 75 patients who would be treated for six months and have the option to enroll in an extension study.  These trials will be randomized, placebo-controlled and will enroll verified ITP patients with platelet counts below 30,000 platelets per microliter of blood.   The goal of the trials will be to achieve a durable platelet count increase to over 50,000 platelets per microliter of blood.  Rigel expects top line data from these studies in 2015.

"These events provide clarity to Rigel's pipeline. We now have a clear picture of the Phase 3 program for fostamatinib in ITP and we p
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Rigel to Present at Stifel Healthcare Conference
2. Rigel To Focus On ITP, DLE And Dry Eye
3. Rigels R343 Did Not Meet Primary Endpoint in Asthma Study
4. Rigel Announces Second Quarter 2013 Financial Results
5. Rigel Will Resume Responsibility for Fostamatinib Program
6. Rigels R348 to Initiate Phase 2 Clinical Trial in Dry Eye
7. Rigel Announces First Quarter 2013 Financial Results
8. Rigel Announces Fourth Quarter and Year End 2012 Financial Results
9. Rigel Announces Participation at Two Investor Conferences
10. Rigel to Present at BIO CEO & Investor Conference
11. Rigel to Present at Jefferies 2012 Global Healthcare Conference in London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , June 29, 2015  PDL BioPharma, Inc. ... entered into a credit agreement with CareView Communications, Inc. ... to $40 million of secured debt financing. CareView is ... on patient care monitoring. Under the credit ... million of debt financing in two tranches of $20 ...
(Date:6/29/2015)... Minn. , June 29, 2015 EnteroMedics ... of devices that use neuroblocking technology to treat obesity, ... it has commenced an underwritten public offering of units. ... stock, Series A warrants to purchase common stock and ... purchase of units in the offering would result in ...
(Date:6/29/2015)... , June 29, 2015  Allergan plc ... intends to release second quarter 2015 financial results ... open of the U.S. financial markets. The Company will ... a.m. Eastern Daylight Time on Thursday, August 6, ... to access the call is U.S./ Canada ...
Breaking Medicine Technology:PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 2PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 4EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 2Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 3
... Radiologic (vRad), a technology-enabled national radiology practice, has again ... market segment by independent research and consulting firm KLAS. ... interviews conducted by KLAS and is published in the ... Software & Professional Services report. In ...
... Reportlinker.com announces that a new market research report ... Novo Nordisk A/S: PharmaVitae Profile ... This analysis examines the historical ... prescription pharmaceutical sector. The profile encompasses global company ...
Cached Medicine Technology:Virtual Radiologic Ranked #1 for Teleradiology Services for Third Consecutive Year 2Reportlinker Adds Novo Nordisk A/S: PharmaVitae Profile 2
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... of aspiring data scientists and analysts who are currently attending an accredited American ... growth of data has provided new insight into healthcare, the environment, political campaigns, ...
(Date:6/30/2015)... ... June 30, 2015 , ... Curly Hair Solutions™ is honoured to attend ... in the US, featuring products from all over the world. For the first time ... a line of hair styling products focused entirely on meeting the needs of all ...
(Date:6/29/2015)... ... , ... Aespala Medspa and Plastic Surgery is proud to introduce the newest ... Dr. Dreyfuss received his medical degree from Emory University in Atlanta before completing a ... Fellowship at the University of Chicago. He has taught and practiced medicine in the ...
(Date:6/29/2015)... ... June 30, 2015 , ... Career Step, ... website intended for executives and administrators with hospitals, healthcare providers, and insurance companies. ... product is a result of comprehensive research and implementation of web design and ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... group series as part of its support program. This discussion series is part ... and other support services to those affected by mesothelioma. , The six week ...
Breaking Medicine News(10 mins):Health News:Izenda Offers Embedded BI and Analytics Scholarship 2Health News:Izenda Offers Embedded BI and Analytics Scholarship 3Health News:Curly Hair Solutions™ Showcases Entire Curl Keeper™ Collection at Cosmoprof Las Vegas July 12 - 14 2Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 2Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 3Health News:Career Step Launches New Website to Better Meet Needs of Partners, Clients and Others Searching for Corporate Training Solutions 2Health News:Mesothelioma Organization Provides Support for Patients and Families 2Health News:Mesothelioma Organization Provides Support for Patients and Families 3
... fats should be listed on food labels to help cut ... // ,These experts putting forward their arguments in this ... in order to combat the UK's number one killer, estimated ... in Europe. ,In addition cardiovascular disease is reported ...
... activities under a common umbrella, Orchid Chemicals & Pharmaceuticals Ltd ... acquiring a 26 per cent stake // , for over ... a majority 74 per cent stake in Bexel Pharma and ... part of an agreement reached between the two companies to ...
... Indoor Air Act, celebrating its third anniversary, has reduced ... //according to a study conducted by RTI International. ... State Department of Health’s Tobacco Control Program, exposure to ... New York in the year following the implementation of ...
... in fertility treatment if they donate eggs for controversial cloning ... a scheme for ‘egg sharing' so as to advance work ... agree for this scheme and pass on their spare eggs ... IVF treatment by almost half. , ,The researcher ...
... a drugs trial which went wrong could now develop serious ... ,The six volunteers of the trials at Northwick Park ... year. ,Martyn Day, a solicitor for several of ... most terrible future". ,Parexel, a clinical research organization, ...
... An Oregon Health & Science University study has demonstrated ... can assist in keeping// a tab on the pattern ... the initial signs of onset of dementia. The study ... the 10th International Conference on Alzheimer's Disease and Related ...
Cached Medicine News:Health News:Scientists Push for Labeling of all Fats to Avoid Heart Disease 2Health News:New York’s Secondhand Smoke Exposure Continues to Declin 2Health News:IVF Price To Be Reduced If Women Opt For Egg Sharing Scheme 2Health News:IVF Price To Be Reduced If Women Opt For Egg Sharing Scheme 3Health News:Sensors placed at home capable of signaling onset of early signs of dementia in elderly 2Health News:Sensors placed at home capable of signaling onset of early signs of dementia in elderly 3
... third-generation allergy test , 3gAllergy is a ... provides quantitative determination of allergen-specific IgE at ... and lot-to-lot reproducibility. The assay delivers reliable ... you identify, monitor and manage patients with ...
... System is part of a series of modular ... ranging from 3.5 to 8.0 mm. Matching a ... system provides convenience and flexibility for the orthopaedic ... system may be customized using two of three ...
The DePuy ACE 8.0mm Cannulated Cancellous Screw incorporates TiMAX to provide superior strength, fatigue resistance and a lower modulus of elasticity when compared to similar stainless steel devices....
... The VersaNail System is a complete system ... to use with TTC fusion surgery. The ... specialists and integrates clinical research and engineering ... Because every patient is different, and because ...
Medicine Products: